Rentokil Initial (LON:RTO – Get Free Report) had its target price upped by investment analysts at Jefferies Financial Group from GBX 540 to GBX 550 in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside of 20.91% from the company’s previous close.
Separately, Stifel Nicolaus reiterated a “hold” rating and issued a GBX 390 price target on shares of Rentokil Initial in a research note on Thursday, March 5th. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Rentokil Initial presently has a consensus rating of “Hold” and a consensus target price of GBX 427.86.
View Our Latest Research Report on RTO
Rentokil Initial Stock Down 0.9%
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Featured Articles
- Five stocks we like better than Rentokil Initial
- The gold chart Wall Street is terrified of…
- Gold Is About to Do Something It Hasn’t in 90 Years
- Buy this Gold Stock Before May 15th, 2026
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- Blink Charging: 3,648%. NIO: 1,755%. None of them are Tesla.
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
